Lv5
1308 积分 2024-03-13 加入
The crystal structure of SFCA-I, CA3.18FE14.663+AL1.34FE0.822+O28, a homologue of the aenigmatite structure type, and new crystal structure refinements of beta-CFF, CA2.99FE14.303+FE0.552+O25 and MG-free SFCA, CA2.45FE9.043+AL1.74FE0.162+SI0.6O20
1个月前
已关闭
Patterning nano-scale molecular gradients and metal particles on surfaces
1个月前
已关闭
Affinity maturation of antibodies using phage display
1个月前
已完结
Affinity maturation of antibodies using phage display
1个月前
已关闭
By-passing immunization: building high affinity human antibodies by chain shuffling
1个月前
已完结
Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies
1个月前
已完结
治疗性抗体半衰期改造研究进展
1个月前
已完结
CRISPR-Cas systems for editing, regulating and targeting genomes
1个月前
已完结
Visual rehabilitation in patients with myopic maculopathy: our experience
1个月前
已关闭
Preliminary study on developing ocular formulations for natural antioxidants to prevent long-term complications associated with high myopia
1个月前
已关闭
皖公网安备34019202002308
